Amgen Inc. has submitted for approval from the European Medicines Agency its drug used to treat a mutation of non-small cell lung cancer.
Staff from Valley facilities of Kaiser Permanente will participate in the health care organization’s 90-second video for “The Rose Parade’s New Year Celebration presented by Honda” on New Year’s Day.
Sterling Healthcare Logistics in Calabasas has acquired ABS Vaccines, which operates as a contract negotiator between health care providers and drug manufacturers or vendors.
Quanta Inc. in Burbank has agreed to acquire a 51 percent stake in Medolife Rx, a Wyoming company that uses patented polarization technology to make anti-viral and immune-boosting therapeutics.
Amgen Inc. has licensed one of its investigational pipeline drugs to Medicines Development for Global Health for the treatment of tuberculosis and leprosy.
The AIDS Healthcare Foundation in Los Angeles staged a socially distant protest at Amgen headquarters in Thousand Oaks in response to the biotech giant’s refusal to sell orphan drugs to nonprofit entities at a reduced price.
A nursing strike planned for the holidays was narrowly avoided, with Hospital Corporation of America and Service Employees International Union 121 RN coming to a tentative contract agreement.
Hospitals in the Valley region have started administering the COVID-19 vaccine made by Pfizer Inc.
Antelope Valley Hospital and Kentucky-based Kindred Healthcare have entered into a joint venture to build and operate a new specialty hospital in Lancaster.
The number of available intensive care unit beds has plummeted in Los Angeles County, with only 92 ICU beds available countywide.
The U.S. Food and Drug Administration has approved the first at-home COVID-19 test, developed by a biotech company with ties to the Valley region.
Nurses at two hospitals in the Valley region have called a 10-day strike from Dec. 24 to Jan. 3 to protest unfair labor practices.
Westlake Village BioPartners has announced two new funds totaling $500 million to invest in life science startups and construct lab facilities for them.
Atara Biotherapeutics and German pharmaceutical giant Bayer have entered into a strategic collaboration to develop therapies for solid tumors.
MannKind Corp. announced it has acquired Pennsylvania-based QrumPharma Inc. for $3.5 million in cash and more than 3 million shares of its common stock.